Cargando…

Chromosome banding analysis and genomic microarrays are both useful but not equivalent methods for genomic complexity risk stratification in chronic lymphocytic leukemia patients

Genome complexity has been associated with poor outcome in patients with chronic lymphocytic leukemia (CLL). Previous cooperative studies established five abnormalities as the cut-off that best predicts an adverse evolution by chromosome banding analysis (CBA) and genomic microarrays (GM). However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramos-Campoy, Silvia, Puiggros, Anna, Beà, Sílvia, Bougeon, Sandrine, Larráyoz, María José, Costa, Dolors, Parker, Helen, Rigolin, Gian Matteo, Ortega, Margarita, Blanco, María Laura, Collado, Rosa, Salgado, Rocío, Baumann, Tycho, Gimeno, Eva, Moreno, Carolina, Bosch, Francesc, Calvo, Xavier, Calasanz, María José, Cuneo, Antonio, Strefford, Jonathan C., Nguyen-Khac, Florence, Oscier, David, Haferlach, Claudia, Schoumans, Jacqueline, Espinet, Blanca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883543/ https://www.ncbi.nlm.nih.gov/pubmed/33691382 http://dx.doi.org/10.3324/haematol.2020.274456

Ejemplares similares

TP53 Abnormalities Are Underlying the Poor Outcome Associated with Chromothripsis in Chronic Lymphocytic Leukemia Patients with Complex Karyotype
por: Ramos-Campoy, Silvia, et al.
Publicado: (2022)

Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL)
por: Puiggros, Anna, et al.
Publicado: (2022)

The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp Lymphoma
por: Oscier, David, et al.
Publicado: (2022)

Genomic arrays identify high-risk chronic lymphocytic leukemia with genomic complexity: a multicenter study
por: Leeksma, Alexander C., et al.
Publicado: (2020)

Genomic arrays for the identification of high-risk chronic lymphocytic leukemia: ready for prime time?
por: Cuneo, Antonio, et al.
Publicado: (2021)

Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
por: Mansouri, Larry, et al.
Publicado: (2023)

Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY
por: Mansouri, Larry, et al.
Publicado: (2022)

Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go
por: Puiggros, Anna, et al.
Publicado: (2014)

Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions
por: Puiggros, Anna, et al.
Publicado: (2017)

Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations
por: Baliakas, Panagiotis, et al.
Publicado: (2022)

A Tangle of Genomic Aberrations Drives Multiple Myeloma and Correlates with Clinical Aggressiveness of the Disease: A Comprehensive Review from a Biological Perspective to Clinical Trial Results
por: Sessa, Mariarosaria, et al.
Publicado: (2020)

First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era
por: Urso, Antonio, et al.
Publicado: (2023)

The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial
por: Oscier, David, et al.
Publicado: (2016)

Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial
por: Larrayoz, M, et al.
Publicado: (2017)

Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma
por: Jaramillo Oquendo, Carolina, et al.
Publicado: (2019)

A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia
por: Hernández, José Ángel, et al.
Publicado: (2015)

Impact of human milk on the transcriptomic response of fetal intestinal epithelial cells reveals expression changes of immune-related genes
por: Gimeno-Alcañiz, José V., et al.
Publicado: (2019)

IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
por: Nadeu, Ferran, et al.
Publicado: (2020)

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
por: Blanco, Gonzalo, et al.
Publicado: (2016)

Shared genomic segment analysis with equivalence testing
por: Horpaopan, Sukanya, et al.
Publicado: (2020)

GAPDH Pseudogenes and the Quantification of Feline Genomic DNA Equivalents
por: Helfer-Hungerbuehler, A. Katrin, et al.
Publicado: (2013)

Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks
por: Rendeiro, André F., et al.
Publicado: (2016)

The P-factor and its genomic and neural equivalents: an integrated perspective
por: Sprooten, Emma, et al.
Publicado: (2021)

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms: reponse to the comments from the Francophone Group of Hematological Cytogenetics (GFCH)
por: Rack, K. A., et al.
Publicado: (2020)

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms
por: Rack, K. A., et al.
Publicado: (2019)

Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
por: Parker, H, et al.
Publicado: (2016)

Epigenomic profiling of myelofibrosis reveals widespread DNA methylation changes in enhancer elements and ZFP36L1 as a potential tumor suppressor gene that is epigenetically regulated
por: Martínez-Calle, Nicolás, et al.
Publicado: (2019)

Adrenomedullin Contributes to Age-Related Memory Loss in Mice and Is Elevated in Aging Human Brains
por: Larrayoz, Ignacio M., et al.
Publicado: (2017)

Mutation Patterns of 16 Genes in Primary and Secondary Acute Myeloid Leukemia (AML) with Normal Cytogenetics
por: Fernandez-Mercado, Marta, et al.
Publicado: (2012)

Unsupervised Analysis of Array Comparative Genomic Hybridization Data from Early-Onset Colorectal Cancer Reveals Equivalence with Molecular Classification and Phenotypes()
por: Arriba, María, et al.
Publicado: (2016)

Longitudinal copy number, whole exome and targeted deep sequencing of 'good risk' IGHV-mutated CLL patients with progressive disease
por: Rose-Zerilli, M J J, et al.
Publicado: (2016)

A quality index for equivalent uniform dose
por: Henríquez, Francisco Cutanda, et al.
Publicado: (2011)

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry
por: Sargas, Claudia, et al.
Publicado: (2023)

Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
por: Aguilera-Diaz, Almudena, et al.
Publicado: (2020)

Equivalent Latitude Computation Using Regions of Interest (ROI)
por: Añel, Juan A., et al.
Publicado: (2013)

Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups
por: Cuneo, Antonio, et al.
Publicado: (2014)

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms
por: Aguirre-Ruiz, Paula, et al.
Publicado: (2020)

The molecular pathogenesis of the NUP98-HOXA9 fusion protein in acute myeloid leukemia
por: Rio-Machin, A, et al.
Publicado: (2017)

Clinico‐biological features and outcome of patients with splenic marginal zone lymphoma with histological transformation
por: Bastidas‐Mora, Gabriela, et al.
Publicado: (2021)

With the finished human genome in hand, what next?
por: Collado-Vides, Julio, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_ba4sb8kjei4d35jsr909aftmbg